Cingulate Therapeutics' Unattributed - II Round

Cingulate Therapeutics raised a round of funding on July 11, 2018. Investors include Werth Family Investment Associates.

Cingulate Therapeutics, LLC (CTx) is a privately held, clinical stage biopharmaceutical company focused on the development of innovative new products for the treatment of Attention Deficit/Hyperactivi…

Articles about Cingulate Therapeutics' Unattributed - II Round: